Bioton (LTS:0DTR) Institutional Ownership : 0.28% (As of Jun. 10, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Bioton Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bioton's institutional ownership is 0.28%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bioton's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bioton's Float Percentage Of Total Shares Outstanding is 0.00%.

Bioton Institutional Ownership Historical Data

The historical data trend for Bioton's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioton Institutional Ownership Chart

Bioton Historical Data

The historical data trend for Bioton can be seen below:

	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	0.31	0.28	0.28	0.28	0.28	0.28	0.28	0.28	0.28	0.28

Bioton Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Bioton (LTS:0DTR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (LTS:0DTR) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

BIO:Poland 7U5:Germany

Address

Ul. Staro?ci?ska 5, Warszawa, POL, 02-516

Website

http://www.bioton.pl

Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.

Bioton (LTS:0DTR) Headlines

No Headlines